FDA Drug Application (202123) for COMPLERA by GILEAD SCIENCES INC

Back to FDA Applications sponsored by GILEAD SCIENCES INC

Application Number202123
Product Number001
FormTABLET;ORAL
Dosage200MG;EQ 25MG BASE;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCOMPLERA
Active IngredientEMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE



Back to FDA Applications sponsored by GILEAD SCIENCES INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.